drugset / Trial / NCT06376110

Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production

NCT06376110 ↗

RandomizedSequentialSingle-blindTreatment

Summary

This is a split-face, single-blind study assessing the use of an antioxidant serum with a series of acne laser treatments to reduce sebum production in healthy male and female subjects between the ages of 18 and 65 years, inclusive, with Fitzpatrick skin types I-VI.

Timeline

Start
2024-04-24
Primary completion
2025-04-24
Completion
2025-04-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Silymarin CF Unknown — Topical

Indications